Menu Search
Equities

China Feihe Ltd

CHFLF:PKC

China Feihe Ltd

Actions
  • Price (USD)0.4848
  • Today's Change0.00 / 0.00%
  • Shares traded9.30k
  • 1 Year change-26.94%
  • Beta--
Data delayed at least 15 minutes, as of Apr 29 2024 13:05 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

China Feihe Limited is an investment holding company mainly engaged in the production and sale of dairy products and the sale of nutritional supplements. The Company's main products include infant milk formula products, adult milk-powder, liquid milk, goat milk infant formula, and a small amount of soybean powder, among others. The Company's milk formula product series include super-premium Astrobaby, Super-premium Organic Zhenzhi and so on. The Company conducts its businesses within the domestic market and to overseas markets such as the United States.

  • Revenue in HKD (TTM)21.10bn
  • Net income in HKD3.66bn
  • Incorporated2012
  • Employees9.55k
  • Location
    China Feihe LtdStar City International BuildingC-16th Floor, 10 Jiuxianqiao RoadChaoyang DistrictBEIJING ChinaCHN
  • Websitehttps://www.feihe.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.